Considering that ZNF750 is hypomethylated at its promoter and hypermethylated as mRNA, we hypothesize that epigenetic and epitranscriptional modifications may function together to modulate gene expression in some cases, complicating the study of the molecular mechanism governing NPC progression. Here, ZNF750 is linked to nasopharyngeal carcinoma.